ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $184 | -47.3% | 22,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $349 | -99.9% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $320,000 | +3.2% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $310,000 | -20.1% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $388,000 | +34.7% | 22,000 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $288,000 | +540.0% | 20,000 | -5.7% | 0.00% | – |
| Q2 2019 | $45,000 | -75.9% | 21,200 | +66.9% | 0.00% | -100.0% |
| Q1 2019 | $187,000 | +152.7% | 12,700 | +19.8% | 0.00% | – |
| Q4 2018 | $74,000 | -60.4% | 10,600 | -16.5% | 0.00% | -100.0% |
| Q3 2018 | $187,000 | -23.0% | 12,700 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $243,000 | +3.8% | 12,700 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $234,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |